Evidence map›Paper›PMID 9708352›Full record

ArticleNucleosides & nucleotides

Two hydrolase resistant analogues of diadenosine 5',5"'-P1,P3-triphosphate for studies with Fhit, the human fragile histidine triad protein.

G M Blackburn, X Liu, A Rösler, C Brenner

Open access · greenAbstract read
In one paragraph

Article in Nucleosides & nucleotides. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Designed FHIT alleles establish that Fhit-induced apoptosis in cancer cells is limited by substrate binding.Proceedings of the National Academy of Sciences of the United States of America · 2003
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Genetic, biochemical, and crystallographic characterization of Fhit-substrate complexes as the active signaling form of Fhit.Proceedings of the National Academy of Sciences of the United States of America · 1998
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

G M BlackburnDepartment of Chemistry, Sheffield University, UK. g.m.blackburn@sheffield.ac.uk
X Liu
A Rösler
C Brenner
University of Sheffield · GBThomas Jefferson University · US

Funding

Mechanism of Dnmt1 Up-regulation by Fhit LossR01CA075954 · NCI · UNIVERSITY OF IOWA · PI BRENNER, CHARLES M · 1997 to 2012
$3.0M
NCI NIH HHS CA56336NCI NIH HHS CA75954NCI NIH HHS R01 CA075954
6 · The paper itself

Abstract

The design and synthesis of analogues of diadenosine 5',5"'-P1,P3-triphosphate that are resistant to pyrophosphate hydrolysis is described in relation to their rôle in signalling and tumorigenesis involving the Fhit protein, the human fragile histidine triad protein, which is a novel Ap3A binding/cleaving protein.

Indexed as

Neoplasm ProteinsAcid Anhydride HydrolasesBinding SitesBis(5'-adenosyl)triphosphataseDinucleoside PhosphatesDNA-Binding ProteinsHumansHydrolysisMolecular StructurePolyphosphatesProteinsStereoisomerismAcid Anhydride HydrolasesBis(5'-adenosyl)triphosphatasediadenosine tetraphosphatediadenosine triphosphateDinucleoside PhosphatesDNA-Binding ProteinsNeoplasm ProteinsPolyphosphatesProteins

Identifiers

PMID9708352
PMCPMC2556045
OpenAlexW2065016493

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.